Your browser doesn't support javascript.
loading
Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients.
Balandín, Bárbara; Pintado, Vicente; Pérez-Pedrero, María José; Martínez-Sagasti, Fernando; Sancho-González, Milagros; Soriano-Cuesta, Cruz; Gesso, Cristina Martín-Dal; Chicot, Marta; de Luna, Rafael Ruiz; Asensio-Martín, María José; Catalan, Mercedes; Díaz-Díaz, Juan José; Carbonell, Nieves; Iranzo, Reyes; Royuela, Ana; Ballesteros, Daniel.
Afiliação
  • Balandín B; Department of Critical Care Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Electronic address: balandinmoreno@gmail.com.
  • Pintado V; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Pérez-Pedrero MJ; Department of Critical Care Medicine, Hospital Universitario de Toledo, Toledo, Spain.
  • Martínez-Sagasti F; Department of Critical Care Medicine, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Sancho-González M; Department of Critical Care Medicine, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Soriano-Cuesta C; Department of Critical Care Medicine, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Gesso CM; Department of Critical Care Medicine, Hospital Universitario del Sudeste, Madrid, Spain.
  • Chicot M; Department of Critical Care Medicine, Hospital Universitario de La Princesa, Madrid, Spain.
  • de Luna RR; Department of Critical Care Medicine, Hospital Universitario Fundación de Alcorcón, Madrid, Spain.
  • Asensio-Martín MJ; Department of Critical Care Medicine, Hospital Universitario La Paz, Madrid, Spain.
  • Catalan M; Department of Critical Care Medicine, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Díaz-Díaz JJ; Department of Critical Care Medicine, Hospital Universitario de Gran Canaria Doctor Negrín; Gran Canaria, Spain.
  • Carbonell N; Department of Critical Care Medicine, Hospital Clínico Universitario de Valencia.
  • Iranzo R; Department of Anesthesiology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Royuela A; Clinical Biostatistics, Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, Madrid, Spain.
  • Ballesteros D; Department of Critical Care Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
Int J Antimicrob Agents ; 63(5): 107121, 2024 May.
Article em En | MEDLINE | ID: mdl-38408494
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefalosporinas / Infecções por Bactérias Gram-Negativas / Estado Terminal / Cefiderocol / Antibacterianos Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefalosporinas / Infecções por Bactérias Gram-Negativas / Estado Terminal / Cefiderocol / Antibacterianos Idioma: En Ano de publicação: 2024 Tipo de documento: Article